2021
DOI: 10.3390/molecules26247611
|View full text |Cite
|
Sign up to set email alerts
|

Recent Advancements in the Development of Anti-Breast Cancer Synthetic Small Molecules

Abstract: Among all cancer types, breast cancer (BC) still stands as one of the most serious diseases responsible for a large number of cancer-associated deaths among women worldwide, and diagnosed cases are increasing year by year worldwide. For a very long time, hormonal therapy, surgery, chemotherapy, and radiotherapy were used for breast cancer treatment. However, these treatment approaches are becoming progressively futile because of multidrug resistance and serious side effects. Consequently, there is a pressing d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(6 citation statements)
references
References 127 publications
0
3
0
Order By: Relevance
“…Choe and his coworkers (2020) [42] discovered that OPE has anticancer activities against breast cancer. The apoptosis system was defective, and there was unregulated growth in cancerous cells, while as in the case of malignant cells, cell proliferation was prevented by cell division with natural extracts.…”
Section: Anticancer Propertiesmentioning
confidence: 99%
“…Choe and his coworkers (2020) [42] discovered that OPE has anticancer activities against breast cancer. The apoptosis system was defective, and there was unregulated growth in cancerous cells, while as in the case of malignant cells, cell proliferation was prevented by cell division with natural extracts.…”
Section: Anticancer Propertiesmentioning
confidence: 99%
“…Due to BC heterogeneity, the first-line treatment of the disease typically involves one or multiple chemotherapeutics having distinct modes of action such as antimetabolites, immunotherapeutics, hormonal/endocrine drugs, DNA alkylating agents, ion modulators, antimitotic agents, etc. [ 4 , 5 ]. The long-term survival of breast cancer patients depends on the tumor subtype, stage at the time of diagnosis, specific tumor markers, and the effectiveness of treatment.…”
Section: Introductionmentioning
confidence: 99%
“…In order to reduce the aggressiveness of breast cancer and to prevent cancer cell multiplication, invasion and metastasis, it is urgently necessary to create more effective and safe treatments. [6][7][8][9] Cancer cells possess the ability to self-renew and can develop all types of cells. Hemostasis, embryogenesis, and proper development are all largely regulated by several signaling cascades.…”
Section: Introductionmentioning
confidence: 99%